Clinical Trials
9 trialsNCT00003086 2020-07-14
Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer
Louisiana State University Health Sciences Center Shreveport
Phase 1/2 Terminated
NCT00006123 2018-05-16
Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer
Dana-Farber Cancer Institute
Phase 1/2 Withdrawn
NCT00002627 2014-01-10
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00002628 2014-01-10
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00002780 2013-12-19
Biological Therapy in Treating Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00003425 2013-04-26
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
University of Kentucky
Phase 1/2 Completed
NCT00002837 2012-07-31
High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT00004085 2011-06-22
Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Phase 1/2 Completed
NCT00002509 2010-10-01
High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer
Temple University
Phase 1/2 Completed